
Turning the Immune System into an Equal Opportunity Cancer Killer
Results from a small clinical trial comprising 86 cancer patients have prompted scientists to rethink how different cancers are classified and treated. The drug being assessed was Keytruda, a recent addition to oncologists’ arsenal of cancer immunotherapy drugs. Unlike traditional chemotherapies, which poison and kill cancer cells directly, cancer immunotherapy recruits the body’s own self-defense machinery to attack tumors. Although our immune systems are very good … Continue reading Turning the Immune System into an Equal Opportunity Cancer Killer